<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P8363>	<http://www.wikidata.org/entity/statement/Q113944271-B07B9095-7669-4C22-812F-B91A12822603> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P8005>	<http://www.wikidata.org/entity/Q76649708> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q30612> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P1813>	"FIGHT-210"@en .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P8363>	<http://www.wikidata.org/entity/Q78089383> .
<http://www.wikidata.org/entity/Q113944271>	<http://schema.org/description>	"\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk .
<http://www.wikidata.org/entity/Q113944271>	<http://schema.org/description>	"ensayo cl\u00EDnico"@es .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P1132>	<http://www.wikidata.org/entity/statement/Q113944271-7229AE45-8AAE-4AC5-9790-5767E8836C69> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P1813>	<http://www.wikidata.org/entity/statement/Q113944271-329DE641-AAA2-47CA-A1E0-476C35863D2C> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P6099>	<http://www.wikidata.org/entity/statement/Q113944271-50BE184F-F442-45B6-A1DC-81F35698E66D> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.w3.org/2000/01/rdf-schema#label>	"Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration"@en .
<http://www.wikidata.org/entity/Q113944271>	<http://schema.org/description>	"klinisch onderzoek"@nl .
<http://www.wikidata.org/entity/Q113944271>	<http://schema.org/description>	"\u062A\u062C\u0631\u0628\u0629 \u0633\u0631\u064A\u0631\u064A\u0629"@ar .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P3098>	"NCT05253807" .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P582>	<http://www.wikidata.org/entity/statement/Q113944271-3EC8A39A-CDD2-4CE9-95E3-F76477C0930D> .
<http://www.wikidata.org/entity/Q113944271>	<http://schema.org/description>	"ensayu cl\u00EDnicu"@ast .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P3098>	<http://www.wikidata.org/entity/statement/Q113944271-B813F09F-87F8-4CE8-B34C-B00FF60E98B1> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P1476>	"A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Advanced Non-Small Cell Lung Cancer With an FGFR Alteration Who Progressed on Previous Therapy (FIGHT 210)"@en .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P580>	<http://www.wikidata.org/entity/statement/Q113944271-FB23F8EF-F80B-4719-AA10-8CDDD5A6DCB7> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q113944271-C3CEE350-36F3-4022-A040-50B6BCD4315D> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P6153>	<http://www.wikidata.org/entity/Q30279623> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q142> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P580>	"2022-04-29T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration"@en .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q113944271-347B9755-FC3A-4783-9225-B70DB9DC9B4C> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P6099>	<http://www.wikidata.org/entity/Q42824440> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q113944271-10A9AC51-3426-4CA8-BE3D-B844AD4C64D6> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q113944271-4386EFC4-C5B0-46F3-AD1A-8F5DAD4259E0> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q30> .
<http://www.wikidata.org/entity/Q113944271>	<http://schema.org/description>	"clinical trial"@en .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P2899>	"18"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q113944271-3CE0FDB5-4A09-4425-8755-4183490003FE> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q113944271-9FB8CC39-90EB-45E2-BAE5-ADA90E1A53A3> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P4135>	"99"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q38> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q183> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q113944271-FE9DD6D3-E418-4691-B7E8-8CA7C7A9A346> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P6153>	<http://www.wikidata.org/entity/statement/Q113944271-9A087FBB-BD48-4FD8-AF59-255F6F4C0987> .
<http://www.wikidata.org/entity/Q113944271>	<http://schema.org/name>	"Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration"@en .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P8005>	<http://www.wikidata.org/entity/statement/Q113944271-692B45AA-2999-4052-A6D5-6F37CC6B68E0> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P4135>	<http://www.wikidata.org/entity/statement/Q113944271-D658645F-BD58-4D1F-9713-31082291A398> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P582>	"2026-01-19T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P1132>	"125"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/P2899>	<http://www.wikidata.org/entity/statement/Q113944271-B33385D4-F6FE-4A65-AD86-10E5BBAD7344> .
<http://www.wikidata.org/entity/Q113944271>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q29> .